-
公开(公告)号：US20190015024A1
公开(公告)日：2019-01-17
申请号：US16035206
申请日：2018-07-13
Applicant: Bigfoot Biomedical, Inc.
Inventor： Lane Desborough , Bryan Mazlish , Sabine Kabel-Eckes , Jeff Boissier
Abstract: A system for displaying blood glucose information includes a blood glucose monitoring device configured to monitor blood glucose levels of a user, and a display. The system may also include one or more processors, and a non-transitory computer-readable medium containing instructions that, when executed by the one or more processors, cause the system to perform operations. The operations may include obtaining the blood glucose levels from the blood glucose monitoring device, where the blood glucose levels include at least a current blood glucose level and a historic blood glucose level. The operations may also include presenting the current blood glucose level at a first location on the display based on a first scale, and presenting the historic blood glucose level at a second location on the display based on a second scale different from the first scale.
-
公开(公告)号：US20240415450A1
公开(公告)日：2024-12-19
申请号：US18821778
申请日：2024-08-30
Applicant: Bigfoot Biomedical, Inc.
Inventor： Bryan Mazlish , Sabine Kabel-Eckes , Shannon Sieber , Jeff Boissier , George Crothall , Yean Wah Chan
Abstract: Systems, methods, and devices provide alarms and alerts in an on-body networked diabetes management system. Methods may include receiving glucose sensor data from a continuous glucose monitor and determining a dosage of insulin delivery based at least in part on the glucose sensor data. The method may include detecting an alarm or alert condition, and sending a wireless communication regarding the alarm or alert condition to a remote user-interface device. The method may include triggering an audible, visual, or haptic alarm or alert on the insulin delivery device unless an acknowledgement of the alarm or alert condition is received within a predetermined period of time.
-
公开(公告)号：USD928199S1
公开(公告)日：2021-08-17
申请号：US29642766
申请日：2018-04-02
Applicant: Bigfoot Biomedical, Inc.
Designer： Bryan Mazlish , Sabine Kabel-Eckes , Jeff Boissier , Bethany Leigh Salmon
-
公开(公告)号：US11957888B2
公开(公告)日：2024-04-16
申请号：US17647688
申请日：2022-01-11
Applicant: Bigfoot Biomedical, Inc.
Inventor： Lane Desborough , Bryan Mazlish , Andrew Bochenko , Ross Naylor , Jeff Boissier , Sabine Kabel-Eckes
IPC: G06F3/04817 , A61M5/172 , A61M5/32 , G06F3/0482 , G06F3/04847 , G16H20/10 , G16H20/17 , G16H50/20 , G06F3/04883 , G16H10/60 , G16H40/63
CPC classification number: A61M5/3202 , A61M5/1723 , G06F3/04817 , G06F3/0482 , G06F3/04847 , G16H20/10 , G16H20/17 , G16H50/20 , A61M2205/3303 , A61M2205/3306 , A61M2205/3561 , A61M2205/50 , A61M2205/505 , A61M2205/52 , A61M2230/201 , G06F3/04883 , G16H10/60 , G16H40/63
Abstract: A method may include displaying at least three icons on a user interface of a mobile device, including a first icon associated with the at least three icons associated with a first carbohydrate level, a second icon associated with the at least three icons associated with a second carbohydrate level, and a third icon associated with the at least three icons associated with a third carbohydrate level. The method may also include receiving a user selection of one of the three icons through the user interface of the mobile device, and determining an insulin bolus level from the user selection. The method may also include communicating the insulin bolus level to an insulin delivery device.
-
公开(公告)号：US11229751B2
公开(公告)日：2022-01-25
申请号：US15717845
申请日：2017-09-27
Applicant: Bigfoot Biomedical, Inc.
Inventor： Lane Desborough , Bryan Mazlish , Andrew Bochenko , Ross Naylor , Jeff Boissier , Sabine Kabel-Eckes
IPC: A61M5/172 , A61M5/32 , G16H20/17 , G16H50/20 , G16H20/10 , G06F3/0481 , G06F3/0482 , G06F3/0484 , G16H10/60 , G16H40/63 , G06F3/0488
Abstract: A method may include displaying at least three icons on a user interface of a mobile device, including a first icon associated with the at least three icons associated with a first carbohydrate level, a second icon associated with the at least three icons associated with a second carbohydrate level, and a third icon associated with the at least three icons associated with a third carbohydrate level. The method may also include receiving a user selection of one of the three icons through the user interface of the mobile device, and determining an insulin bolus level from the user selection. The method may also include communicating the insulin bolus level to an insulin delivery device.
-
Patent Agency Ranking
公开(公告)号：US20210401367A1
公开(公告)日：2021-12-30
申请号：US17444003
申请日：2021-07-29
Applicant: Bigfoot Biomedical, Inc.
Inventor： Bryan Mazlish , Sabine Kabel-Eckes , Shannon Sieber , Jeff Boissier , George Crothall , Yean Wah Chan
Abstract: Systems, methods, and devices provide alarms and alerts in an on-body networked diabetes management system. Methods may include receiving glucose sensor data from a continuous glucose monitor and determining a dosage of insulin delivery based at least in part on the glucose sensor data. The method may include detecting an alarm or alert condition, and sending a wireless communication regarding the alarm or alert condition to a remote user-interface device. The method may include triggering an audible, visual, or haptic alarm or alert on the insulin delivery device unless an acknowledgement of the alarm or alert condition is received within a predetermined period of time.
-
公开(公告)号：US20190385728A1
公开(公告)日：2019-12-19
申请号：US16442281
申请日：2019-06-14
Applicant: Bigfoot Biomedical, Inc.
Inventor： Jacob Bowland , Bethany Leigh Salmon , Jennifer Martin Block , Alexandra Elena Constantin , Sabine Kabel-Eckes , Jeff Boissier
Abstract: A method for presenting insulin therapy setting recommendations associated with a therapy insight for a person with diabetes (PWD) at an electronic device. The method includes, at a device with one or more processors, memory, and a display, displaying on a dashboard of a PWD, at the display a first layer. The first layer includes a therapy insight corresponding to a PWD. The therapy insight generated based in part on insulin therapy data of the PWD. The therapy insight corresponds to insulin therapy of the PWD. The therapy insight comprises clinical advice for insulin-based management of PWDs diabetes. The first layer also includes an insulin therapy recommendation associated with the therapy insight. The insulin therapy recommendation corresponds to a pattern of behavior associated with the insulin-based management of the PWDs diabetes wherein the first layer overlays at least a portion of a second layer. The first layer overlays at least a portion of a second layer.
-
公开(公告)号：US20190274624A1
公开(公告)日：2019-09-12
申请号：US16335163
申请日：2017-12-12
Applicant: Bigfoot Biomedical, Inc.
Inventor： Bryan Mazlish , Sabine Kabel-Eckes , Shannon Sieber , Jeff Boissier , George Crothall , Yean Wah Chan
Abstract: Systems, methods, and devices provide alarms and alerts in an on-body networked diabetes management system. Methods may include receiving glucose sensor data from a continuous glucose monitor and determining a dosage of insulin delivery based at least in part on the glucose sensor data. The method may include detecting an alarm or alert condition, and sending a wireless communication regarding the alarm or alert condition to a remote user-interface device. The method may include triggering an audible, visual, or haptic alarm or alert on the insulin delivery device unless an acknowledgement of the alarm or alert condition is received within a predetermined period of time.
-
公开(公告)号：US12076160B2
公开(公告)日：2024-09-03
申请号：US17444003
申请日：2021-07-29
Applicant: Bigfoot Biomedical, Inc.
Inventor： Bryan Mazlish , Sabine Kabel-Eckes , Shannon Sieber , Jeff Boissier , George Crothall , Yean Wah Chan
CPC classification number: A61B5/4839 , A61B5/002 , A61B5/14532 , A61B5/746 , A61B5/4848
Abstract: Systems, methods, and devices provide alarms and alerts in an on-body networked diabetes management system. Methods may include receiving glucose sensor data from a continuous glucose monitor and determining a dosage of insulin delivery based at least in part on the glucose sensor data. The method may include detecting an alarm or alert condition, and sending a wireless communication regarding the alarm or alert condition to a remote user-interface device. The method may include triggering an audible, visual, or haptic alarm or alert on the insulin delivery device unless an acknowledgement of the alarm or alert condition is received within a predetermined period of time.
-
公开(公告)号：USD911355S1
公开(公告)日：2021-02-23
申请号：US29642496
申请日：2018-03-29
Applicant: Bigfoot Biomedical, Inc.
Designer： Sabine Kabel-Eckes , Jeff Boissier , Jennifer Martin Block , Bryan Mazlish
-
-
-
-
-
-
-
-
-
Search Results
21
records
(took 0.023 seconds)
